Free T Concentration Mapping is a diagnostic and clinical monitoring strategy that involves precisely measuring the bioavailable, unbound fraction of testosterone (Free T) across different physiological states or time points. Total testosterone measurements are insufficient because they include protein-bound hormone, which is largely inactive. Mapping the free concentration provides a direct assessment of the hormone available to engage with androgen receptors in target tissues. This data is essential for accurately diagnosing and managing androgen deficiency.
Origin
This methodology stems from advancements in clinical chemistry and endocrinology, recognizing that the biologically active fraction of a hormone is the free component. The term “mapping” implies a detailed, contextualized assessment, often contrasting with a single, isolated measurement. It is a refinement of traditional hormone testing protocols.
Mechanism
Approximately 98% of circulating testosterone is bound to proteins, primarily Sex Hormone Binding Globulin (SHBG) and albumin. Only the small fraction that remains unbound is considered free and can readily diffuse into cells to exert its biological effects. Accurate concentration mapping requires advanced laboratory techniques, such as equilibrium dialysis, to isolate and quantify this minute, yet physiologically critical, fraction.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.